Gastric adenocarcinoma extremely well differentiated with cylindrical cells: case report
Keywords:
extremely well differentiated adenocarcinoma, early gastric cancer, ciliated metaplasia.Abstract
The extremely well differentiated gastric adenocarcinoma corresponds to an entity initially described in 1984, the epithelium of the gastric mucosa where the finding corresponds to a histologically benign entity but with an aggressive behavior. Subsequently, Pelayo Correa described in carcinogenesis cascade of gastric cancer the "point of no return" the onset of atrophic gastritis and intestinal metaplasia, the latter conventionally type described small intestine and colon, as precursor lesions for the development of adenocarcinoma intestinal type gastric In the case presented, we found an 80-year-old female patient with a history of hypertension and hypertensive heart disease in the dilated phase, with symptomatology of melenic evacuations, early satiety, asthenia, adynamia and weight loss. Radiological and endoscopic studies are performed where they report high lesion, large (10cm), located in the fundus, with initial report of Borrmann I gastric cancer, however, later explorations demonstrated the non-invasion of the submucosal lesion (lifting test positive) and histopathological findings allowed endoscopic mucosal resection of the same in "piece meal" satisfactorily in multiple sessions, with total improvement of symptoms. A brief bibliographic review of the subject is made in the presence of rare histological presentation of ciliated metaplasia in an early gastric lesión.
Downloads
References
Silverberg SG, Hurt WG. Minimal deviation adenocarcinoma ("adenoma malignum") of the cervix: a reappraisal. Am J Obstet Gynecol. 1975;121:971–975.
Araki K, Okajima K, Nakata K, Kurokawa A. A case of gastric cancer with unusual histologic findings. Pathol Clin Med. 1984;2:1366–1371
Yao, T., Utsunomiya, T., Oya, M., Nishiyama, K., y Tsuneyoshi, M. (2006). Adenocarcinoma de estómago extremadamente bien diferenciado: características clínico-patológicas e inmunohistoquímicas. World Journal of Gastroenterology: WJG , 12 (16), 2510-2516. http://doi.org/10.3748/wjg.v12.i16.2510
Correa, Pelayo. Cáncer gástrico: una enfermedad infecciosa Revista Colombiana de Cirugía, vol. 26, núm. 2, abril-junio, 2011, pp. 111-117. http://www.redalyc.org/articulo.oa?id=355534499002
Rubio, C. A., Nesi, G., Zampi, G. C., de Ruiz, P. A., Jessurun, J., Jónasson, J., … Owen, D. (2005). Gastric ciliated metaplasia. A study of 3406 gastrectomy specimens from dwellers of the Atlantic and the Pacific basins. Journal of Clinical Pathology, 58(6), 605–610. http://doi.org/10.1136/jcp.2004.021865
Asociación japonesa de cáncer gástrico. Clasificación japonesa del carcinoma gástrico: 3ª edición en inglés. Cáncer gástrico 2011. http://doi.org/10.1007/s10120-011-0041-5
The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach and colon. Gastrointest Endosc 2003; 58: S3-S43.
Jarvi O, Lauren P. On the role of heterotopias of the intestinal epithelium in the pathogenesis of gastric cancer. Acta Pathol Microbiol Scand. 1951; 29: 26-44
Gotoda T. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer. 2000; 3: 219-25.
. Lee H. Do we have enough evidence for expanding the indications of ESD for EGC? World J Gastroenterol. 2011; 17(21): 2597-2601.
Villasmil, Miguel, Anato, Rafael, Dias, Carla, Landaeta, Jorge, Soto, José, Martinez, Yolette, DiGirolamo, Cristina, Ortega, Roberto, Gonzalez, Oscar, León, Kyra, Zuramay, Gioconda, & León, Keyra. (2011). Cáncer Gástrico Temprano o Precoz: revisión de la literatura. Gen, 65(3), 244-247. Recuperado en 11 de junio de 2018, de http://www.scielo.org.ve/scielo.php?script=sci_arttext&pid=S0016-35032011000300017&lng=es&tlng=es
Japanese Gastric Cancer Association Gastric Cancer (2011) 14: 113. https://doi.org/10.1007/s10120-011-0042-4
Torikata C, Mukai M, Kawakita H.. Ultrastructure of metaplastic ciliated cells in human stomach. Virchows Arch A Pathol Anat Histopathol. 1989;414(2):113-9.
Okuda T, Ogata T. An electronmicroscopic study of ciliated cells in the human gastric mucus. Arch Histol Jpn. 1976;39:149–56.
Rubio CA, Kato Y. Ciliated metaplasia in the gastric mucosa. Studies in Japanese patients. Gann. 1986;77:282–6.
Rubio, C., Serck-Hanssen, A. Ciliated Metaplasia in the Gastric Mucosa II. In a European Patient with Gastric Carcinoma. Path. Res. Pract. 181,382-384 (1986).
Rubio, C. A., Nesi, G., Zampi, G. C., de Ruiz, P. A., Jessurun, J., Jónasson, J., … Owen, D. (2005). Gastric ciliated metaplasia. A study of 3406 gastrectomy specimens from dwellers of the Atlantic and the Pacific basins. Journal of Clinical Pathology, 58(6), 605–610. http://doi.org/10.1136/jcp.2004.021865
Rubio, C., Stermmermann, G., Hayashi, T. Ciliated Gastric Cells among Japanese Living in Hawaii. Jpn. J. Cancer Res. 82, 86-89, January 1991.
Spicer, Z., Miller, M., Andringa, A., Riddle, T., Duffy, J., Doetschman, T., and Shull, G. Stomachs of Mice Lacking the Gastric H, K-ATPase a-Subunit Have Achlorhydria, Abnormal Parietal Cells, and Ciliated Metaplasia. The Journal Of Biological Chemistry. Vol. 275, No. 28, Issue Of July 14, Pp. 21555–21565, 2000.
Tilma, R., Dimmler, A., H¨afner, M., Brabletz, T., Kirchner, T., Faller, G. Aberrant expression of TTF-1 and forkhead factor HFH-4 in atrophic gastritis and ciliated metaplasia suggests gastric broncho-pulmonary transdetermination. Journal of Pathology J Pathol 2005; 206: 383–387.
Kimura, K., Gastritis And Gastric Cancer. Gastroenterology Clinics Of North America. Volume 29 - Number 3 * September 2000.
Downloads
How to Cite
Issue
Section
License
Usted es libre de:
- Compartir — copiar y redistribuir el material en cualquier medio o formato
- Adaptar — remezclar, transformar y construir a partir del material
- para cualquier propósito, incluso comercialmente.
Bajo los siguientes términos:
-
Atribución — Usted debe dar crédito de manera adecuada, brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.
- No hay restricciones adicionales — No puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otras a hacer cualquier uso permitido por la licencia.